Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

SHC vs DBVT vs IQV vs STRL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SHC
Sotera Health Company

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$4.47B
5Y Perf.-42.1%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-18.4%
IQV
IQVIA Holdings Inc.

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$30.32B
5Y Perf.+5.7%
STRL
Sterling Infrastructure, Inc.

Engineering & Construction

IndustrialsNASDAQ • US
Market Cap$24.89B
5Y Perf.+4974.5%

SHC vs DBVT vs IQV vs STRL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SHC logoSHC
DBVT logoDBVT
IQV logoIQV
STRL logoSTRL
IndustryMedical - Diagnostics & ResearchBiotechnologyMedical - Diagnostics & ResearchEngineering & Construction
Market Cap$4.47B$1712.35T$30.32B$24.89B
Revenue (TTM)$1.19B$0.00$16.63B$2.88B
Net Income (TTM)$118M$-168M$1.39B$347M
Gross Margin55.3%26.1%22.8%
Operating Margin34.9%13.9%17.0%
Forward P/E16.3x14.1x59.1x
Total Debt$2.27B$22M$16.17B$350M
Cash & Equiv.$346M$194M$1.98B$391M

SHC vs DBVT vs IQV vs STRLLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SHC
DBVT
IQV
STRL
StockNov 20May 26Return
Sotera Health Compa… (SHC)10057.9-42.1%
DBV Technologies S.… (DBVT)10081.6-18.4%
IQVIA Holdings Inc. (IQV)100105.7+5.7%
Sterling Infrastruc… (STRL)1005074.5+4974.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: SHC vs DBVT vs IQV vs STRL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: STRL leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. DBV Technologies S.A. is the stronger pick specifically for capital preservation and lower volatility. IQV also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
SHC
Sotera Health Company
The Income Pick

SHC is the clearest fit if your priority is income & stability.

  • Dividend streak 2 yrs, beta 1.32
Best for: income & stability
DBVT
DBV Technologies S.A.
The Defensive Pick

DBVT is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.

  • Lower volatility, beta 1.26, Low D/E 12.8%, current ratio 3.67x
  • Beta 1.26, current ratio 3.67x
  • Beta 1.26 vs STRL's 2.54, lower leverage
Best for: sleep-well-at-night and defensive
IQV
IQVIA Holdings Inc.
The Value Pick

IQV is the clearest fit if your priority is valuation efficiency.

  • PEG 0.35 vs STRL's 1.33
  • Lower P/E (14.1x vs 59.1x), PEG 0.35 vs 1.33
Best for: valuation efficiency
STRL
Sterling Infrastructure, Inc.
The Growth Play

STRL carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 17.7%, EPS growth 13.4%, 3Y rev CAGR 12.1%
  • 176.9% 10Y total return vs IQV's 166.5%
  • 17.7% revenue growth vs DBVT's -100.0%
  • 12.0% margin vs DBVT's 0.3%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthSTRL logoSTRL17.7% revenue growth vs DBVT's -100.0%
ValueIQV logoIQVLower P/E (14.1x vs 59.1x), PEG 0.35 vs 1.33
Quality / MarginsSTRL logoSTRL12.0% margin vs DBVT's 0.3%
Stability / SafetyDBVT logoDBVTBeta 1.26 vs STRL's 2.54, lower leverage
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)STRL logoSTRL+351.7% vs IQV's +16.5%
Efficiency (ROA)STRL logoSTRL13.7% ROA vs DBVT's -89.0%

SHC vs DBVT vs IQV vs STRL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SHCSotera Health Company
FY 2025
Service
85.6%$996M
Product
14.4%$168M
DBVTDBV Technologies S.A.

Segment breakdown not available.

IQVIQVIA Holdings Inc.
FY 2025
Research And Development Solutions
54.5%$8.9B
Technology And Analytics Solutions
40.6%$6.6B
Contract Sales And Medical Solutions
4.8%$788M
STRLSterling Infrastructure, Inc.
FY 2025
E-Infrastructure Solutions Segment
58.9%$1.5B
Transportation Solutions Segment
25.7%$641M
Building Solutions Segment
15.4%$383M

SHC vs DBVT vs IQV vs STRL — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLSTRLLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

SHC leads this category, winning 3 of 6 comparable metrics.

IQV and DBVT operate at a comparable scale, with $16.6B and $0 in trailing revenue. Profitability is closely matched — net margins range from 12.0% (STRL) to 8.3% (IQV). On growth, STRL holds the edge at +91.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSHC logoSHCSotera Health Com…DBVT logoDBVTDBV Technologies …IQV logoIQVIQVIA Holdings In…STRL logoSTRLSterling Infrastr…
RevenueTrailing 12 months$1.2B$0$16.6B$2.9B
EBITDAEarnings before interest/tax$517M-$112M$3.5B$575M
Net IncomeAfter-tax profit$118M-$168M$1.4B$347M
Free Cash FlowCash after capex$112M-$151M$2.7B$440M
Gross MarginGross profit ÷ Revenue+55.3%+26.1%+22.8%
Operating MarginEBIT ÷ Revenue+34.9%+13.9%+17.0%
Net MarginNet income ÷ Revenue+9.9%+8.3%+12.0%
FCF MarginFCF ÷ Revenue+9.4%+16.1%+15.3%
Rev. Growth (YoY)Latest quarter vs prior year+10.0%+8.4%+91.6%
EPS Growth (YoY)Latest quarter vs prior year+2.9%+91.5%+15.0%+141.4%
SHC leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

IQV leads this category, winning 5 of 7 comparable metrics.

At 22.8x trailing earnings, IQV trades at a 74% valuation discount to STRL's 86.5x P/E. Adjusting for growth (PEG ratio), IQV offers better value at 0.56x vs STRL's 1.95x — a lower PEG means you pay less per unit of expected earnings growth.

MetricSHC logoSHCSotera Health Com…DBVT logoDBVTDBV Technologies …IQV logoIQVIQVIA Holdings In…STRL logoSTRLSterling Infrastr…
Market CapShares × price$4.5B$1712.35T$30.3B$24.9B
Enterprise ValueMkt cap + debt − cash$6.4B$1712.35T$44.5B$24.9B
Trailing P/EPrice ÷ TTM EPS58.04x-0.76x22.79x86.50x
Forward P/EPrice ÷ next-FY EPS est.16.26x14.06x59.12x
PEG RatioP/E ÷ EPS growth rate0.56x1.95x
EV / EBITDAEnterprise value multiple21.09x12.97x50.58x
Price / SalesMarket cap ÷ Revenue3.84x1.86x10.00x
Price / BookPrice ÷ Book value/share7.41x0.66x4.67x22.70x
Price / FCFMarket cap ÷ FCF29.95x14.78x68.64x
IQV leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

STRL leads this category, winning 6 of 9 comparable metrics.

STRL delivers a 32.3% return on equity — every $100 of shareholder capital generates $32 in annual profit, vs $-130 for DBVT. DBVT carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to SHC's 3.75x. On the Piotroski fundamental quality scale (0–9), SHC scores 6/9 vs IQV's 4/9, reflecting solid financial health.

MetricSHC logoSHCSotera Health Com…DBVT logoDBVTDBV Technologies …IQV logoIQVIQVIA Holdings In…STRL logoSTRLSterling Infrastr…
ROE (TTM)Return on equity+20.6%-130.2%+22.1%+32.3%
ROA (TTM)Return on assets+3.7%-89.0%+4.7%+13.7%
ROICReturn on invested capital+11.8%+8.7%+38.9%
ROCEReturn on capital employed+13.3%-145.7%+11.0%+28.5%
Piotroski ScoreFundamental quality 0–96446
Debt / EquityFinancial leverage3.75x0.13x2.44x0.32x
Net DebtTotal debt minus cash$1.9B-$172M$14.2B-$41M
Cash & Equiv.Liquid assets$346M$194M$2.0B$391M
Total DebtShort + long-term debt$2.3B$22M$16.2B$350M
Interest CoverageEBIT ÷ Interest expense2.38x-189.82x3.10x27.17x
STRL leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

STRL leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in STRL five years ago would be worth $350,047 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, STRL leads with a +351.7% total return vs IQV's +16.5%. The 3-year compound annual growth rate (CAGR) favors STRL at 167.8% vs IQV's -2.0% — a key indicator of consistent wealth creation.

MetricSHC logoSHCSotera Health Com…DBVT logoDBVTDBV Technologies …IQV logoIQVIQVIA Holdings In…STRL logoSTRLSterling Infrastr…
YTD ReturnYear-to-date-11.4%+4.9%-20.7%+154.2%
1-Year ReturnPast 12 months+19.2%+110.4%+16.5%+351.7%
3-Year ReturnCumulative with dividends+4.6%+19.7%-5.9%+1819.6%
5-Year ReturnCumulative with dividends-36.3%-69.1%-23.8%+3400.5%
10-Year ReturnCumulative with dividends-37.6%-87.0%+166.5%+17694.1%
CAGR (3Y)Annualised 3-year return+1.5%+6.2%-2.0%+167.8%
STRL leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — DBVT and STRL each lead in 1 of 2 comparable metrics.

DBVT is the less volatile stock with a 1.26 beta — it tends to amplify market swings less than STRL's 2.54 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. STRL currently trades 91.3% from its 52-week high vs IQV's 72.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSHC logoSHCSotera Health Com…DBVT logoDBVTDBV Technologies …IQV logoIQVIQVIA Holdings In…STRL logoSTRLSterling Infrastr…
Beta (5Y)Sensitivity to S&P 5001.32x1.26x1.33x2.54x
52-Week HighHighest price in past year$19.85$26.18$247.05$888.95
52-Week LowLowest price in past year$10.80$7.53$134.65$171.38
% of 52W HighCurrent price vs 52-week peak+78.9%+76.3%+72.3%+91.3%
RSI (14)Momentum oscillator 0–10056.548.158.588.3
Avg Volume (50D)Average daily shares traded3.1M252K1.6M498K
Evenly matched — DBVT and STRL each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — SHC and IQV each lead in 1 of 1 comparable metric.

Analyst consensus: SHC as "Buy", DBVT as "Buy", IQV as "Buy", STRL as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs -39.8% for STRL (target: $488).

MetricSHC logoSHCSotera Health Com…DBVT logoDBVTDBV Technologies …IQV logoIQVIQVIA Holdings In…STRL logoSTRLSterling Infrastr…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$22.00$46.33$225.63$488.20
# AnalystsCovering analysts1215449
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises2021
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+4.1%+0.3%
Evenly matched — SHC and IQV each lead in 1 of 1 comparable metric.
Key Takeaway

STRL leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). SHC leads in 1 (Income & Cash Flow). 2 tied.

Best OverallSterling Infrastructure, In… (STRL)Leads 2 of 6 categories
Loading custom metrics...

SHC vs DBVT vs IQV vs STRL: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is SHC or DBVT or IQV or STRL a better buy right now?

For growth investors, Sterling Infrastructure, Inc.

(STRL) is the stronger pick with 17. 7% revenue growth year-over-year, versus 5. 7% for Sotera Health Company (SHC). IQVIA Holdings Inc. (IQV) offers the better valuation at 22. 8x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate Sotera Health Company (SHC) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SHC or DBVT or IQV or STRL?

On trailing P/E, IQVIA Holdings Inc.

(IQV) is the cheapest at 22. 8x versus Sterling Infrastructure, Inc. at 86. 5x. On forward P/E, IQVIA Holdings Inc. is actually cheaper at 14. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: IQVIA Holdings Inc. wins at 0. 35x versus Sterling Infrastructure, Inc. 's 1. 33x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — SHC or DBVT or IQV or STRL?

Over the past 5 years, Sterling Infrastructure, Inc.

(STRL) delivered a total return of +34. 0%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: STRL returned +176. 9% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SHC or DBVT or IQV or STRL?

By beta (market sensitivity over 5 years), DBV Technologies S.

A. (DBVT) is the lower-risk stock at 1. 26β versus Sterling Infrastructure, Inc. 's 2. 54β — meaning STRL is approximately 102% more volatile than DBVT relative to the S&P 500. On balance sheet safety, DBV Technologies S. A. (DBVT) carries a lower debt/equity ratio of 13% versus 4% for Sotera Health Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — SHC or DBVT or IQV or STRL?

By revenue growth (latest reported year), Sterling Infrastructure, Inc.

(STRL) is pulling ahead at 17. 7% versus 5. 7% for Sotera Health Company (SHC). On earnings-per-share growth, the picture is similar: Sotera Health Company grew EPS 68. 8% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, STRL leads at 12. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SHC or DBVT or IQV or STRL?

Sterling Infrastructure, Inc.

(STRL) is the more profitable company, earning 11. 7% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 11. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SHC leads at 33. 8% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — SHC leads at 55. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SHC or DBVT or IQV or STRL more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, IQVIA Holdings Inc. (IQV) is the more undervalued stock at a PEG of 0. 35x versus Sterling Infrastructure, Inc. 's 1. 33x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, IQVIA Holdings Inc. (IQV) trades at 14. 1x forward P/E versus 59. 1x for Sterling Infrastructure, Inc. — 45. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

08

Which pays a better dividend — SHC or DBVT or IQV or STRL?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is SHC or DBVT or IQV or STRL better for a retirement portfolio?

For long-horizon retirement investors, IQVIA Holdings Inc.

(IQV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+166. 5% 10Y return). Sterling Infrastructure, Inc. (STRL) carries a higher beta of 2. 54 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IQV: +166. 5%, STRL: +176. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SHC and DBVT and IQV and STRL?

These companies operate in different sectors (SHC (Healthcare) and DBVT (Healthcare) and IQV (Healthcare) and STRL (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SHC is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; IQV is a mid-cap quality compounder stock; STRL is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SHC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

IQV

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

STRL

High-Growth Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 45%
  • Net Margin > 7%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.